Status:
UNKNOWN
Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer
Lead Sponsor:
Hospital General de Ciudad Real
Conditions:
Resectable Pancreatic Adenocarcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
A randomized, multidisciplinary study, Phase II-III clinical trial.The study is opened to the incorporation of other centers that would increase the power of the obtained results . Our hypothesis cons...
Detailed Description
According to the incidence in the area of the University General Hospital, Ciudad Real, HGUCR, authors will include a population of 42 patients, n = 21 in each group, I and II, with diagnosis of adeno...
Eligibility Criteria
Inclusion
- · Resectable pancreatic adenocarcinoma
Exclusion
- Voluntary refusal to participate in the trial
- Existence of distant disease that contraindicates the surgical treatment
- Patients with preoperative or intraoperative locoregional unresectable pancreatic cancer
- Existence of synchronous neoplastic disease
- Exclusion after perioperative anesthetic study
Key Trial Info
Start Date :
July 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT03251365
Start Date
July 27 2017
End Date
December 31 2024
Last Update
August 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Ciudad Real, HGUCR
Ciudad Real, Spain, 13005